ALB and pulmonary edema: In the albumin dose-finding trial (ALISAH), Suarez et al. [7] demonstrated that while all the aSAH patients in the 0.625 g/kg/day tier tolerated the treatment, one patient receiving 1.25 g/kg/day and two patients receiving 1.875 g/kg/day were not able to tolerate the treatment due to pulmonary edema [7].